Ibogaine Clinic and Research Center Ensure Safety Protocol of Ibogaine Hydrochloride.

MIAMI, FL / ACCESSWIRE / September 28, 2023 / Located in Playa Del Carmen, Mexico, David Dardashti owns and operates an ibogaine clinic that both offers treatment to those struggling with addiction and mental health, and also conducts regular research used to conduct the most optimal protocols to ensure the most effective treatment possible. The clinic’s current research ensures optimal dosing of ibogaine hydrochloride on a physiological level. How is this done?

To ensure safety precautions of ibogaine hydrochloride the clinic has conducted an experiment based on the authorisation of twenty different people receiving ibogaine treatment. Blood was drawn prior to treatment and measured once more in the days after treatment. This was essential to properly analyze all vital bioavailability factors.

The research indicated a healthy distribution of biological factors such as various blood cells, blood sugar, insulin, and even testosterone. The test not only demonstrated that ibogaine did not disrupt any biological functionality it also showed stabilization of such entities .Those who displayed low numbers of biological entities tended to see a healthy increase and those with high numbers of biological entities tended to see an increase. This study helped prove ibogaine to not only be safe on a physiological level, it demonstrated its medicinal properties.

The ibogaine clinic is in the process of creating a detailed analysis of the report based on doctor approved authorization. This will allow those concerned about the safety protocol of ibogaine proven results to ensure a healthy and successful treatment. The clinic continues to measure success by enhancing more effective protocol. The ibogaine dosage is essential for the most optimal treatment. By combining these lab approved results the facility extends its research in order and expands its horizons.

For more information about DR. Ashok J. Bharucha, MD, please visit his credentials at

https://docs.google.com/document/d/1JC_V4qKvWBGvBm7H2lRE0olqdHex01iT/edit?usp=sharing&ouid=104855725655878546082&rtpof=true&sd=true

News Source: PinionNewswire

Media Contacts:
Gavriel Dardashti
gavriel@ibogaineclinic.com

SOURCE: IBOGAINE

View source version on accesswire.com:
https://www.accesswire.com/788530/ibogaine-clinic-and-research-center-ensure-safety-protocol-of-ibogaine-hydrochloride

Staff

Recent Posts

Defence Completes 2nd Tranche of Financing

Vancouver, British Columbia--(Newsfile Corp. - March 22, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB:…

6 hours ago

Masimo Corporation Board of Directors Authorizes Management to Evaluate the Separation of Consumer Business

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI), a global leader in noninvasive monitoring technologies and audio products,…

7 hours ago

Axonics Stockholders Approve Merger Agreement with Boston Scientific

IRVINE, Calif.--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX) announced that its stockholders have voted today to adopt…

7 hours ago

Pramana Achieves Industry-Leading Milestone with Digital Pathology 2.0 Technology

Over 6.5 Million Glass Slides Digitized in the Last 12 Months and 15 Billion Images…

7 hours ago

NLS Pharmaceutics Announces Closing of $1.75 Million Registered Direct Offering

ZÜRICH, SWITZERLAND / ACCESSWIRE / March 22, 2024 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or…

7 hours ago